GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

UHT · Sep 30, 2025

UNIVERSAL HEALTH REALTY INCOME TRUST. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0001193125-25-272382Reit
Operating-cash-flow growth69thOwn-history percentile · N=13
Evidence method

Yoy · gp.fundamentals.operating_cash_flow

3.09% · OPTIONAL · VALID

Net-income growth69thOwn-history percentile · N=13
Evidence method

Yoy · gp.fundamentals.net_income

0.48% · CORE · VALID

Revenue growth23thOwn-history percentile · N=13
Evidence method

Yoy · gp.fundamentals.revenue

3.30% · CORE · VALID

Cash and equivalents18thOwn-history percentile · N=17
Evidence method

Level · gp.fundamentals.cash

$6.9M · CORE · VALID

Operating-income growth15thOwn-history percentile · N=13
Evidence method

Yoy · gp.fundamentals.operating_income

-1.13% · OPTIONAL · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History17 statesSelf-history eligible
Period transition

What moved in the state?

Cash Generation Decreased
Previous
12.85%
Current
3.09%
Delta
-9.75%
Earnings Growth Increased
Previous
-14.86%
Current
0.48%
Delta
15.34%
Growth Increased
Previous
0.54%
Current
3.30%
Delta
2.76%
Liquidity Increased
Previous
$6.6M
Current
$6.9M
Delta
$362,000
Profitability Increased
Previous
-7.72%
Current
-1.13%
Delta
6.59%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.